logo
Top Stories
56
45
DollarTree-090115-lg.jpg

Discount retailer Dollar Tree, Inc. on Tuesday reported a loss for the second quarter, reflecting costs related to the acquisition of Family Dollar Stores Inc. and on lower margins that more than offset higher revenues. However, revenues for the quarter missed analysts' expectations and the company forecast revenues for the third quarter as well as fiscal 2015 also below their estimates.

ConstructionSpending-090115.jpg

Reflecting a jump in spending on private construction, the Commerce Department released a report on Tuesday showing that total U.S. construction spending reached its highest level in seven years in the month of July.

BernieSanders-083115-lg.jpg

Vermont Senator Bernie Sanders, I-Vt., has seen a sharp jump in support in the first-in-the-nation caucus state of Iowa, according to a new Des Moines Register/Bloomberg Politics Iowa Poll. The poll found that Sanders is the first choice of 30 percent of likely Democratic caucusgoers.

wallstreet2-103112_01Sep15.jpg

Continuing the recent wild ride by the markets, stocks have moved sharply lower in early trading on Tuesday. The major averages have dropped firmly into negative territory, further offsetting the recovery rally that was seen last week.

BernieSanders-083115.jpg Vermont Senator Bernie Sanders, I-Vt., has seen a sharp jump in support in the first-in-the-nation caucus state of Iowa, according to a new Des Moines Register/Bloomberg Politics Iowa Poll. The poll found that Sanders is the first choice of 30 percent of likely Democratic caucusgoers.
More
Ericcantor-082815.jpg Jeb Bush received a high-profile endorsement in his race for the Republican presidential nomination on Thursday, as former House Majority Leader Eric Cantor, R-Virg., announced his support for the former Florida Governor.
More
IMF-Lagarde-090115.jpgGlobal economic growth is set to moderate and will likely be weaker-than-expected earlier due to sluggish recovery in advanced economies and a further slowdown in emerging economies, International Monetary Fund Managing Director Christine Lagarde said Tuesday.
More
The major U.S. index futures are pointing to a notably lower opening on Tuesday, with sentiment pointing to extreme negativity following the release of lackluster manufacturing data out of China. Chinese growth concerns, which have pushed the markets to the defensive, could intensify, given the ability of China to derail or prop up global growth due to it being the biggest consumer of resources.
Bristol-Myers Squibb Co. (BMY) and AbbVie (ABBV) announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for Empliciti (elotuzumab) for the treatment of multiple myeloma as combination... More
One national guard member was killed and around hundred members of the security forces protecting Ukraine's parliament were wounded in attacks by protesters who surrounded the House while the lawmakers gave initial approval to a bill granting more autonomy...
More
South Korean conglomerate Samsung Electronics Co. (SSNLF) on Monday unveiled its latest smartwatch, the Samsung Gear S2, as it aims to bolster its presence in the global wearable market amid stiff competition from rivals such as Apple Inc. (AAPL). The...
More
Follow RTT
Economic Calendar
DateIndicatorPeriodCountry
09/01/15 14:0Trade BalanceAUG Brazil
09/01/15 14:0ExportsAUG Brazil
09/01/15 14:0ImportsAUG Brazil
09/01/15 10:30PMI ManufacturingAUG Mexico
09/01/15 10:0ISM Manufacturing New Orders IndexAUG United States
09/01/15 10:0ISM Manufacturing Prices Index AUG United States
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
11/30/2015RPRXEnclomiphene citrate product candidate ( formerly known as Androxal)FDA decision on Androxal for secondary hypogonadism
11/30/2015RPRXEnclomiphene (formerly Androxal) (NDA)FDA decision on Enclomiphene for secondary hypogonadism in overweight men
11/27/2015BMYOpdivo (sBLA)FDA decision on Opdivo for expanded use in treating previously untreated patients with unresectable or metastatic melanoma
11/11/2015RHHBYCobimetinib (NDA)FDA decision on Cobimetinib for advanced melanoma
11/11/2015EXELCobimetinib (NDA)FDA decision on Cobimetinib for treatment of patients with BRAF V600 mutation-positive advanced melanoma
Complete FDA Calendar